Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy
- 8 October 2003
- journal article
- Published by Elsevier in Psychiatry Research
- Vol. 120 (3) , 231-238
- https://doi.org/10.1016/s0165-1781(03)00197-5
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's diseaseNeuroscience Letters, 2000
- In vivo Quantification of Brain Volumes in Subcortical Vascular Dementia and Alzheimer’s DiseaseDementia and Geriatric Cognitive Disorders, 1998
- Tau Protein in Cerebrospinal FluidAlzheimer Disease & Associated Disorders, 1998
- Longitudinal study of cerebrospinal fluid levels of tau, Aβ1–40, and Aβ1–42(43) in Alzheimer's disease: A study in JapanAnnals of Neurology, 1998
- Cerebral changes and cerebrospinal fluid β-amyloid in Alzheimer's disease: a study with quantitative magnetic resonance imagingMolecular Psychiatry, 1997
- Reduction of β‐amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's diseaseAnnals of Neurology, 1995
- Tau protein concentrations in cerebrospinal fluid of patients with dementia of the Alzheimer type.Journal of Neurology, Neurosurgery & Psychiatry, 1995
- Increased levels of τ protein in cerebrospinal fluid of patients with alzheimer's disease—correlation with degree of cognitive impairmentAnnals of Neurology, 1995
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Diagnostic evaluation of degenerative and vascular dementia.Stroke, 1983